Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Buckingham

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Nucleic Acids Research|April 12, 2011
Mechanism of activation of methyltransferases involved in translation by the Trm112 'hub' proteinDominique Liger, Liliana Mora, Noureddine Lazar, et al.
JCI Insight|June 8, 2021
TNF blockade uncouples toxicity from antitumor efficacy induced with CD40 chemoimmunotherapyMeredith L Stone, Jesse Lee, Veronica M Herrera, et al.
Scientific Reports|May 12, 2021
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitorsBardia Yousefi, Michael J LaRiviere, Eric A Cohen, et al.
Prostate Cancer and Prostatic Diseases|October 3, 2020
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamideNaomi B Haas, Michael J LaRiviere, Thomas H Buckingham, et al.
Nature Medicine|March 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trialVivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Nucleic Acids Research|April 12, 2011
Mechanism of activation of methyltransferases involved in translation by the Trm112 'hub' proteinDominique Liger, Liliana Mora, Noureddine Lazar, et al.
JCI Insight|June 8, 2021
TNF blockade uncouples toxicity from antitumor efficacy induced with CD40 chemoimmunotherapyMeredith L Stone, Jesse Lee, Veronica M Herrera, et al.
Scientific Reports|May 12, 2021
Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitorsBardia Yousefi, Michael J LaRiviere, Eric A Cohen, et al.
Prostate Cancer and Prostatic Diseases|October 3, 2020
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamideNaomi B Haas, Michael J LaRiviere, Thomas H Buckingham, et al.
Nature Medicine|March 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trialVivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, et al.
Pageof 9